Revolution Medicines, Inc. (NASDAQ:RVMDW) Sees Significant Increase in Short Interest

Revolution Medicines, Inc. (NASDAQ:RVMDW) saw a significant growth in short interest during the month of April. As of April 15th, there was short interest totaling 2,787 shares, a growth of 284.4% from the March 31st total of 725 shares. Based on an average daily volume of 466,253 shares, the short-interest ratio is presently 0.0 days.

Revolution Medicines Price Performance

Revolution Medicines stock opened at $4.43 on Monday. Revolution Medicines has a fifty-two week low of $0.07 and a fifty-two week high of $6.23. The stock’s fifty day moving average is $2.48 and its two-hundred day moving average is $1.59.

Revolution Medicines Company Profile

Revolution Medicines (NASDAQ:RVMDW) is a clinical-stage oncology company focused on discovering and developing small-molecule therapies that target the RAS signaling pathway. The company’s scientific approach centers on designing molecules that selectively inhibit mutant RAS proteins and key regulators of RAS-driven cancers, with the goal of addressing tumor types that have historically been resistant to targeted therapies.

Revolution Medicines has advanced multiple pipeline candidates into clinical trials, including RMC-4630, a selective SHP2 inhibitor, and RMC-6236, an oral pan-RAS inhibitor designed to block signaling from multiple RAS mutants.